PDT Partners, LLC Buys AbbVie Inc, Cognex Corp, TransUnion, Sells Amazon.com Inc, Boston Scientific Corp, Palo Alto Networks Inc

• New Purchases: ABBV, CGNX, TRU, BIIB, TMO, ROP, V, HD, NCLH, DBX, CPRT, AXTA, FAST, NKTR, SIX, PLAN, BPMC, ZUO, BIG, AGIO, EYE, ESPR, ACIW, LAD, WAT, BTU, SGMO, BOLD, BLDR, RUN, EVTC, WRLD, CCS, NSTG, SIRI, BAND, CWT, IBP, CNSL, NTLA, OSUR, SLDB, TTEK, RUSHA, COLL, ASMB, KTOS, HSKA, TWST, ADMS, CMTL, ITCI, ABEO, TOCA, TITN, TK, CAC, KURA, CLBK, CASA, LPG, CAMT, DNLI, GOGL, BSIG, ACRS, ARCE, AIRG, ABEV, RCUS, DSPG, BREW, SPOK, PTGX, BBW, ECOM, SYRS, CBIO, MNLO, NM,
• Added Positions: SQ, EOG, ALNY, PSTG, HLF, MYL, DXCM, SMAR, MRO, PSX, FIZZ, NUS, TREX, BMRN, CRL, EDIT, IRBT, OLLI, IRTC, AMED, GHDX, SAIL, SHAK, SYNA, SAM, IPHI, TDY, TRUE, ELY, CARG, DIN, ACIA, BNFT, BL, GDOT, MD, PBYI, VCYT, VG, CDNA, CSOD, ELF, SXC, ALKS, WVE, EPZM, HUBG, MTSI, PRFT, TCMD, WK, DESP, RACE, AMAG, AAOI, WIFI, CHGG, CCXI, FOE, LPSN, SSTK, VREX, GOLF, ADTN, APLS, ASRT, BNED, CRCM, CEVA, CLDR, CVGI, DY, ELGX, GSBC, HCI, HMHC, LMNX, HZO, NLS, NPTN, NR, ORBC, SRDX, TNC, TER, VSTO, VSLR, WLDN, LXFR, TPRE, AMRC, AI, BANC, CALX, CSU, SSSS, MCHX, NBTB, RLGT, RECN, RVSB, RYI, TMP, CLUB, UTL, VRTV, NEXA, SALT,
• Reduced Positions: GM, AIG, MA, YELP, XLNX, EXAS, CMG, OKTA, TEAM, NOW, TREE, BCE, SPLK, HLT, MTD, ROKU, IDXX, SBGI, TECH, PODD, MEOH, GRPN, COKE, PII, APPN, CZZ, LGIH, CONN, RTRX, AAXN, DRQ, TPH, WETF, VGR, RAMP, RGEN, FSV, RCII, CORE, GMS, OSIS, NTCT, PATK, FRPT, H, SONO, RDFN, KOS, CIGI, VRTU, PSDO, TA, RNG, HIVE, MODN, WMS, CNNE, CARB, WLH, LXRX, YEXT, JE, JNCE, ZS, ECHO, VOXX, WING, ZVO, ARCO, PRTA, ARD, AUDC, NVMI, ATNI, CPSI, TCS, CYTK, ERII, IDT, IMAX, PI, FRAC, LKFN, MX, MFIN, OCSL, OOMA, PGNX, RMBS, JOE, UCFC,
• Sold Out: AMZN, BSX, PANW, IONS, APC, GILD, CNHI, AXP, WIX, LH, PNW, TSCO, WAB, DATA, EXPE, JNPR, FFIV, MOS, GRUB, ASH, BEAT, MASI, TDC, NOMD, MLNX, LSCC, BOX, NVTA, ONCE, NVRO, HZNP, TNET, UNVR, ACM, CMP, UVV, USFD, HMSY, EFII, PPC, EHTH, QTNA, CCJ, MTRN, WAGE, HIBB, TECK, CM, MGA, BTE, GOOS, ERIE, NSIT, MOV, CSII, CTRL, INOV, KFRC, TAC, UVE, VFF, ATRC, FORR, KNL, PDS, PVG, ZYNE, ABTX, AQ, CECO, EGO, FARO, INTL, MYRG, DOOR, OBNK, PRK, PEBO, UFCS, ABUS, BSTC, CBTX, CRR, CLAR, CRVL, DAKT, HABT, IO, MPX, NWLI, NOA, RARX, RTIX, SPWH, WAAS, SILC, CYCN, CRHM, HBIO, ORN, ZFGN, CETV,

For the details of PDT Partners, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/pdt+partners%2C+llc/current-portfolio/portfolio

1. AbbVie Inc (ABBV) - 1,205,251 shares, 5.18% of the total portfolio. New Position
2. Mettler-Toledo International Inc (MTD) - 44,300 shares, 2.20% of the total portfolio. Shares reduced by 5.54%
3. Bristol-Myers Squibb Company (BMY) - 645,934 shares, 1.73% of the total portfolio. Shares reduced by 0.01%
4. Humana Inc (HUM) - 110,113 shares, 1.73% of the total portfolio. Shares added by 0.01%
5. EOG Resources Inc (EOG) - 285,700 shares, 1.57% of the total portfolio. Shares added by 26.62%

PDT Partners, LLC initiated holding in AbbVie Inc. The purchase prices were between $65.7 and $83.98, with an estimated average price of $78.61. The stock is now traded at around $67.53. The impact to a portfolio due to this purchase was 5.18%. The holding were 1,205,251 shares as of .

PDT Partners, LLC initiated holding in Cognex Corp. The purchase prices were between $40.6 and $56.84, with an estimated average price of $48.13. The stock is now traded at around $45.02. The impact to a portfolio due to this purchase was 1.34%. The holding were 474,214 shares as of .

PDT Partners, LLC initiated holding in TransUnion. The purchase prices were between $63.68 and $73.51, with an estimated average price of $68.4. The stock is now traded at around $83.29. The impact to a portfolio due to this purchase was 0.6%. The holding were 137,600 shares as of .

PDT Partners, LLC initiated holding in Biogen Inc. The purchase prices were between $219.29 and $241.72, with an estimated average price of $230.78. The stock is now traded at around $232.18. The impact to a portfolio due to this purchase was 0.59%. The holding were 42,500 shares as of .

PDT Partners, LLC initiated holding in Thermo Fisher Scientific Inc. The purchase prices were between $257.51 and $295.55, with an estimated average price of $275.13. The stock is now traded at around $277.95. The impact to a portfolio due to this purchase was 0.56%. The holding were 32,500 shares as of .

PDT Partners, LLC initiated holding in Visa Inc. The purchase prices were between $157.26 and $173.85, with an estimated average price of $163.66. The stock is now traded at around $180.19. The impact to a portfolio due to this purchase was 0.55%. The holding were 54,100 shares as of .

PDT Partners, LLC added to a holding in Square Inc by 1138.26%. The purchase prices were between $60.62 and $77.05, with an estimated average price of $69.8. The stock is now traded at around $64.45. The impact to a portfolio due to this purchase was 0.52%. The holding were 131,800 shares as of .

PDT Partners, LLC added to a holding in EOG Resources Inc by 26.62%. The purchase prices were between $81.88 and $107.07, with an estimated average price of $93.07. The stock is now traded at around $77.24. The impact to a portfolio due to this purchase was 0.33%. The holding were 285,700 shares as of .

PDT Partners, LLC added to a holding in Alnylam Pharmaceuticals Inc by 84.87%. The purchase prices were between $65.86 and $92.79, with an estimated average price of $76.69. The stock is now traded at around $83.19. The impact to a portfolio due to this purchase was 0.28%. The holding were 138,800 shares as of .

PDT Partners, LLC added to a holding in Pure Storage Inc by 103.38%. The purchase prices were between $15.27 and $23.38, with an estimated average price of $19.53. The stock is now traded at around $13.67. The impact to a portfolio due to this purchase was 0.28%. The holding were 607,900 shares as of .

PDT Partners, LLC added to a holding in Herbalife Nutrition Ltd by 25.27%. The purchase prices were between $41.25 and $54.37, with an estimated average price of $47.33. The stock is now traded at around $35.71. The impact to a portfolio due to this purchase was 0.25%. The holding were 492,621 shares as of .

PDT Partners, LLC added to a holding in Mylan NV by 41.84%. The purchase prices were between $16.8 and $28.47, with an estimated average price of $22.14. The stock is now traded at around $19.68. The impact to a portfolio due to this purchase was 0.21%. The holding were 628,500 shares as of .

PDT Partners, LLC sold out a holding in Amazon.com Inc. The sale prices were between $1692.69 and $1962.46, with an estimated average price of $1862.37.

PDT Partners, LLC sold out a holding in Boston Scientific Corp. The sale prices were between $34.91 and $42.98, with an estimated average price of $38.41.

PDT Partners, LLC sold out a holding in Palo Alto Networks Inc. The sale prices were between $195.54 and $250.77, with an estimated average price of $224.48.

PDT Partners, LLC sold out a holding in Ionis Pharmaceuticals Inc. The sale prices were between $62.09 and $86.14, with an estimated average price of $70.63.

PDT Partners, LLC sold out a holding in Anadarko Petroleum Corp. The sale prices were between $44.47 and $75.86, with an estimated average price of $67.07.

PDT Partners, LLC sold out a holding in Gilead Sciences Inc. The sale prices were between $61.87 and $69.38, with an estimated average price of $65.76.